About
Gutierrez-Ramos serves as Senior Vice President and Chief Science Officer of Danaher and is a named executive officer. His 2025 personal performance objectives centered on cost reductions, revenue, M&A, AI, innovation and R&D, together with qualitative goals relating to talent development, succession planning and sustainability.
Roles
Danaher Corp.
Senior Vice President & Chief Science Officer · Current role
2020–present
AbbVie, Inc.
Vice President – Drug Discovery · A biopharmaceutical company.
January 2020 – December 2020
AbbVie, Inc.
Global Head of Drug Discovery · Per Danaher's official leadership bio.
—
Pfizer Inc.
Group SVP, Biotherapeutics R&D · Per Danaher's official leadership bio.
—
GlaxoSmithKline
SVP and CEDD Head of Immuno-Inflammation · Per Danaher's official leadership bio.
—
Repertoire Immune Medicines
Founding CEO and President · Per Danaher's official leadership bio.
—
Synlogic
President and Chief Executive Officer · Per Danaher's official leadership bio.
—
Harvard Medical School
Assistant Professor of Genetics · Began his academic career here, per the official bio.
—
Fixed Compensation
FY 2025Salary
$888,460
ComponentAnnual base salary
Bonus
$0
All other compensation
$97,016
Total compensation
$6,243,771
Performance Compensation
Data from FY 2025Cash incentive
Annual cash incentive
$1,530,550
FormCash
Target Opportunity
—
Evaluation periodFY2025
Stock awards
Stock awards
$1,959,422
Formas disclosed
Vestingas disclosed
Also at Danaher Corp.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.